The estimated Net Worth of Jason Hannon is at least $7 Million dollars as of 7 March 2017. Mr. Hannon owns over 97,375 units of Orthofix Medical Inc stock worth over $2,476,646 and over the last 19 years he sold OFIX stock worth over $4,526,386. In addition, he makes $0 as Independent Director at Orthofix Medical Inc.
Jason has made over 65 trades of the Orthofix Medical Inc stock since 2006, according to the Form 4 filled with the SEC. Most recently he exercised 97,375 units of OFIX stock worth $3,390,598 on 7 March 2017.
The largest trade he's ever made was exercising 97,375 units of Orthofix Medical Inc stock on 7 March 2017 worth over $3,390,598. On average, Jason trades about 7,499 units every 44 days since 2005. As of 7 March 2017 he still owns at least 142,336 units of Orthofix Medical Inc stock.
You can see the complete history of Mr. Hannon stock trades at the bottom of the page.
Jason M. Hannon serves as Independent Director of the Company. He currently serves as Chief Executive Officer and as a Director of Mainstay Medical International plc, a global medical device company headquartered in Ireland that is focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions. From September 2016 to August 2017, Mr. Hannon served as President and Chief Operating Officer of NuVasive, Inc., a U.S. publicly-traded medical device company focused on the design, development and marketing of products for the surgical treatment of spine disorders. Prior to that, Mr. Hannon served during the previous 12 years in various roles of increasing responsibility, including as Executive Vice President, International; Executive Vice President, Corporate Development; and General Counsel. Mr. Hannon has a JD degree from Stanford University Law School and a BA degree from the University of California, Berkeley.
Jason Hannon is 48, he's been the Independent Director of Orthofix Medical Inc since 2020. There are 17 older and no younger executives at Orthofix Medical Inc. The oldest executive at Orthofix Medical Inc is Ronald Matricaria, 77, who is the Independent Chairman of the Board.
Jason's mailing address filed with the SEC is 3451 PLANO PARKWAY, , LEWISVILLE, TX, 75056.
Over the last 22 years, insiders at Orthofix Medical Inc have traded over $19,062,472 worth of Orthofix Medical Inc stock and bought 182,076 units worth $5,806,101 . The most active insiders traders include Stuart Essig, Charles R. Kummeth, and Alexis V Lukianov. On average, Orthofix Medical Inc executives and independent directors trade stock every 53 days with the average trade being worth of $179,237. The most recent stock trade was executed by Kevin J. Kenny on 8 January 2024, trading 5,959 units of OFIX stock currently worth $103,687.
orthofix international began in a small farmhouse in verona italy in 1980 when orthopedic researcher giovanni de bastiani recognized the bone’s natural repair capability, a concept he called “dynamization” and with that in mind, he created the first external fixation device. today, orthofix has grown to more than 900 employees with locations in the u.s., italy, germany, france, the uk, brazil, australia and puerto rico. our products help patients in 70 countries around the world. the company is comprised of four strategic business units; biostim, biologics, extremity fixation and spine fixation. our products are widely distributed via the company's sales representatives, distributors and subsidiaries. at orthofix we are committed to clinical research and driven by new product introductions. we are proud of our strong partnerships with organizations such as the texas scottish rite hospital for children in dallas and the musculoskeletal transplant foundation. we take pride in developing
Orthofix Medical Inc executives and other stock owners filed with the SEC include: